Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience

We report on manufacturing outcomes for 41 autologous polyclonal regulatory T cell (PolyTreg) products for 7 different Phase 1 clinical trials over a 10-year period (2011-2020). Data on patient characteristics, manufacturing parameters, and manufacturing outcomes were collected from manufacturing ba...

Full description

Saved in:
Bibliographic Details
Main Authors: Joanna Balcerek, Brian R. Shy, Amy L. Putnam, Lisa M. Masiello, Angela Lares, Florinna Dekovic, Luis Acevedo, Michael R. Lee, Vinh Nguyen, Weihong Liu, Sreenivasan Paruthiyil, Jingying Xu, Ashley S. Leinbach, Jeffrey A. Bluestone, Qizhi Tang, Jonathan H. Esensten
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
regulatory T cell manufacturing
cGMP
ex vivo expansion
cellular therapy
regulatory T cells
Immunologic diseases. Allergy
RC581-607
Online Access:https://doaj.org/article/4fbc3387d354494ba9daa3d9eab90fba
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/4fbc3387d354494ba9daa3d9eab90fba

Similar Items